Ver-246608|CAS 1684386-71-7|DC Chemicals

Cas No.:	1684386-71-7
Chemical Name:	VER-246608
Synonyms:	N-[4-(2-Chloro-5-Methylpyrimidin-4-Yl)phenyl]-N-(4-{[(Difluoroacetyl)amino]methyl}benzyl)-2,4-Dihydroxybenzamide;N-[4-(2-chloro-5-methylpyrimidin-4-yl)phenyl]-N-[[4-[[(2,2-difluoroacetyl)amino]methyl]phenyl]methyl]-2,4-dihydroxybenzamide;N-(4-(2-chloro-5-methylpyrimidin-4-yl)phenyl)-N-(4-((2,2-difluoroacetamido)methyl)benzyl)-2,4-dihydroxybenzamide;N-[4-(2-Chloro-5-methyl-4-pyrimidinyl)phenyl]-N-[[4-[[(2,2-difluoroacetyl)amino]methyl]phenyl]methyl]-2,4-dihyd;VER-246608;N-[4-(2-chloro-5-methylpyrimidin-4-yl)phenyl]-N-({4-[(2,2-difluoroacetamido)methyl]phenyl}methyl)-2,4-dihydroxybenzamide;N-[4-(2-chloro-5-methylpyrimidin-4-yl)phenyl]-N-({4-[(2,2-difluoroacetamido)methyl]phenyl}methyl)-2,4-dihydroxybenzamide;N-(4-(2-chloro-5-methylpyrimidin-4-yl)phenyl)-N-((4-(((2,2-difluoroacetyl)amino)methyl)phenyl)methyl)-2,4-dihydroxybenzamide;N-(4-(2-chloro-5-methylpyrimidin-4-yl)phenyl)-N-((4-(((2,2-difluoroacetyl)amino)methyl)phenyl)methyl)-2,4-dihydroxybenzamide;MS-30103;MS-30103;SZ6;SZ6;AKOS040742812;AKOS040742812;N-[4-(2-Chloro-5-methyl-4-pyrimidinyl)phenyl]-N-[[4-[[(2,2-difluoroacetyl)amino]methyl]phenyl]methyl]-2,4-dihydroxy-benzamide;N-[4-(2-Chloro-5-methyl-4-pyrimidinyl)phenyl]-N-[[4-[[(2,2-difluoroacetyl)amino]methyl]phenyl]methyl]-2,4-dihydroxy-benzamide;1684386-71-7;1684386-71-7;CHEMBL3727577;CHEMBL3727577;VER 246608; VER246608;VER 246608; VER246608;DA-58983;DA-58983;CS-0011787;CS-0011787;SCHEMBL16586236;SCHEMBL16586236;G14475;G14475;Q27465596;Q27465596;GTPL9350;GTPL9350;4v25;4v25;EX-A3785;EX-A3785;LCGNLQSOSJFLKR-UHFFFAOYSA-N;LCGNLQSOSJFLKR-UHFFFAOYSA-N;BDBM50236530;BDBM50236530;BCP29722;BCP29722;HY-12492;HY-12492
SMILES:	ClC1=NC=C(C)C(C2C=CC(=CC=2)N(C(C2C=CC(=CC=2O)O)=O)CC2C=CC(CNC(C(F)F)=O)=CC=2)=N1
Formula:	C₂₈H₂₃ClF₂N₄O₄
M.Wt:	552.956432580948
Purity:	98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

MSDS

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.